Results 221 to 230 of about 25,638 (254)

The Evolution of Medications for Obesity Management. [PDF]

JGH Open
Gill J, Sumithran P.
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Agonists and the Incidence of Atrial Fibrillation in Obese Patients With Heart Failure With Preserved Ejection Fraction and No Diabetes

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
Among obese, non‐diabetic patients with HFpEF, GLP‐1 RA therapy was not significantly associated with incident atrial fibrillation but was associated with lower all‐cause mortality. Prospective studies are needed to clarify the potential role of GLP‐1 RAs in AF prevention. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) reduce
Farah Rassam, Esteban Kosak Lopez, Sarah Sass, Thitiphan Srikulmontri, Evan Isaacs, John Malin, Phuuwadith Wattanachayakul, Olayinka Afolabi‐Brown   +7 more
wiley   +1 more source

Structured Exercise During and After Incretin-Based Pharmacotherapy Discontinuation: A Narrative Review of Mechanisms, Evidence, and Prescription Guidance. [PDF]

Healthcare (Basel)
Zeigler Z, Havenar J, Smith E, Tang L, Marthaler C, Gardner K.   +5 more
europepmc   +1 more source

Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial. [PDF]

Nat Metab
Sandsdal RM, Holt J, Alkhefagie HGA, Jørgensen JR, Juhl CR, Olsen LM, Byberg S, Thirumathyam R, Gliemann L, Stallknecht B, Holst JJ, Hove JD, Bandholm T, Bojsen-Møller KN, Madsbad S, Størling J, Bladbjerg EM, Antoniades C, Jensen SBK, Torekov SS.   +19 more
europepmc   +1 more source

Effect of GLP‐1 receptor agonist on nutrient intake: A narrative review

Nutrition in Clinical Practice, Volume 41, Issue 5, Page 1308-1317, October 2026.
Abstract Humans have a primitive defense mechanism called metabolic adaptation that slows voluntary weight loss. It works by downregulating hormones that reduce food intake and by lowering the metabolic rate. Second‐generation GLP‐1 receptor agonists, such as semaglutide or tirzepatide, promote weight loss by targeting this hormonal system to control ...
Ken Fujioka
wiley   +1 more source

A Novel Approach to Managing "Double Diabetes" in a Pediatric Patient on Insulin Pump Therapy: An Off-Label Use of a Fixed-Ratio Insulin Degludec/Liraglutide Combination. [PDF]

Cureus
Almoallem B, Thalange NK.
europepmc   +1 more source

Real-World Evidence for Existing Anti-Obesity Therapies-The Realities of Treatment Adherence, Tolerability, Access and Patient Satisfaction. [PDF]

Diabetes Obes Metab
Kassem S.
europepmc   +1 more source

Changes in the Adrenal Cortex Induced by Liraglutide Treatment and Exercise in a Rat Model of Menopausal Transition. [PDF]

Cells
Gizdović I, Šošić-Jurjević B, Vlahović D, Ristić N, Lavrnja I, Filipović B, Marina L, Trifunović S.   +7 more
europepmc   +1 more source

Liraglutide-Induced Acute Hepatocellular Injury With Positive Rechallenge: A Case Report and Literature Review. [PDF]

Clin Med Insights Case Rep
Adi M, Ashraf A, Eshimova S, Husanov S.
europepmc   +1 more source

Sex-Specific and Reproductive Status-Dependent Effects of Liraglutide on Metabolic Disorders Associated with Prediabetes. [PDF]

Antioxidants (Basel)
Lebertová L, Marková I, Hüttl M, Černá K, Zapletalová I, Malínská H.   +5 more
europepmc   +1 more source